Justification of Incidental Appendectomy With Respect to Pathohistological Findings

January 11, 2022 updated by: Ognjen Barcot, University Hospital of Split

This study seeks to justify performing an incidental appendectomy according to the following hypotheses:

  1. The frequency of neoplasms in pathohistological (PHD) findings of incidental appendectomy (IA) is significantly higher than in PHD findings in appendectomies for acute appendcitis (AA)
  2. The number needed to treat (NNT) for appendiceal tumors in the elderly is less than 500.
  3. The rate of complicated AA in the elderly population is significantly higher than in the younger age group
  4. NNT IA for complicated appendicitis in the elderly is less than 300.
  5. NNT IA for potential death due to AA in the elderly is less than 500.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

A retrospective cross-sectional study will be done. The archive of all PHD findings will be searched, and then the relevant medical histories at the Clinic of Surgery, University Hospital Center Split in the period from 01.01.2017. to 31.12.2021. The data collection will be done in the period from 01.02.2022. to 31.03.2022. The data collection (extraction) will be done by the main researcher (graduate, Ante Tavra) with at least two other colleagues from the Department of Abdominal-Coloproctological Surgery, University Hospital Center Split (Damir Quien, MD and Dora Bjelanović, MD).

Data will be collected directly from medical history and entered into an overview table. The identity of the respondents will remain secret, and the respondents will be marked exclusively with an identification number. This type of research does not require the informed consent of the patient, and all data collected will be kept in accordance with the provisions of Annex 2 of the Application to Institutional advisory board of UHC Split (approval pending).

Study Type

Observational

Enrollment (Anticipated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Splitsko-dalmatinska
      • Split, Splitsko-dalmatinska, Croatia, 21000
        • University Hospital Split
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All the patients operated in UHC Split Surgery Clinic for colon cancer or acute appendicitis during 5-year period.

Description

Inclusion Criteria:

Adult patients operated for colon tumors who have data on age, sex, data on a previously diagnosed colon tumor, data on incidental appendectomy, and a PHD finding for a removed appendix. Adult patients who have been diagnosed with acute appendicitis and have data on age, sex, data on the diagnosis of acute appendicitis and accompanying PHD findings, newly performed appendectomies.

Exclusion Criteria:

We will exclude from the analysis patients who had previous appendectomy, appendectomy has not been performed or we do not have an accompanying PHD finding of the appendix, and patients younger than 18 years.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Incidental appendectomy (IA)
Group IA will include adult patients operated on for colon tumors who have data on age, sex, data on a previously diagnosed colon tumor, data on incidental appendectomy, and a PHD finding for a removed vermiform appendix.
Surgical removal of the vermiform appendix.
Other Names:
  • Appendicectomy
Acute appendectomy (AA)
Group AA will include adult patients who have been operated due to clinical suspicion of acute appendicitis and have data on age, sex, data on the diagnosis of acute appendicitis and accompanying PHD findings of the performed appendectomy.
Surgical removal of the vermiform appendix.
Other Names:
  • Appendicectomy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of appendiceal neoplasms
Time Frame: 01.01.2017. - 31.12.2021.
Incidence of appendiceal neoplasms in IA which will be compared to the incidence of appendiceal neoplasms AA from respective PH samples.
01.01.2017. - 31.12.2021.
NNT of IA for the appendiceal neoplasm
Time Frame: 01.01.2017. - 31.12.2021.
The number of needed incidental appendectomies necessary to avoid one occurence of appendiceal neoplasm
01.01.2017. - 31.12.2021.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of complicated appendicits
Time Frame: 01.01.2017. - 31.12.2021.
Comparison of incidences of complicated appendicits in young vs elderly
01.01.2017. - 31.12.2021.
NNT of IA for the complicated appendicits in elderly
Time Frame: 01.01.2017. - 31.12.2021.
The number of needed incidental appendectomies necessary to avoid one occurence of complicated appendicitis in elderly
01.01.2017. - 31.12.2021.
NNT of IA for the death due to appendicits in elderly
Time Frame: 01.01.2017. - 31.12.2021.
The number of needed incidental appendectomies necessary to avoid one death from complicated appendicitis in elderly
01.01.2017. - 31.12.2021.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Size of the appendix as a predictor of neoplasm
Time Frame: 01.01.2017. - 31.12.2021.
Receiver operating curve analysis of the size of the vermiform appendix impacting the classification to neoplastic appendix
01.01.2017. - 31.12.2021.
Definition of the elderly group for appendiceal neoplasm
Time Frame: 01.01.2017. - 31.12.2021.
Receiver operating curve analysis of the age of the patient impacting the classification to neoplastic appendix
01.01.2017. - 31.12.2021.
Definition of the elderly group for the complicated appendicitis or death
Time Frame: 01.01.2017. - 31.12.2021.
Receiver operating curve analysis of the age of the patient impacting the classification to the complicated appendicitis or death
01.01.2017. - 31.12.2021.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ognjen Barcot, MD, PhD, Department of surgery, University Hospital Split

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

February 1, 2022

Primary Completion (Anticipated)

April 1, 2022

Study Completion (Anticipated)

June 1, 2022

Study Registration Dates

First Submitted

January 11, 2022

First Submitted That Met QC Criteria

January 11, 2022

First Posted (Actual)

January 21, 2022

Study Record Updates

Last Update Posted (Actual)

January 21, 2022

Last Update Submitted That Met QC Criteria

January 11, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

The data will be available upon reasonable request by the corresponding author (Ognjen Barcot).

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Appendix Tumor

Clinical Trials on Appendectomy

Subscribe